Contribution of adipose tissue to health span and longevity

Interdisciplinary Topics in Gerontology

Volumn 37, Issue , 2010, Pages 1-19

  Huffman, Derek M ^a   Barzilai, Nir ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL FAT; ARTICLE; HEALTH STATUS; HUMAN; LONGEVITY; MORTALITY; OBESITY; PATHOLOGY;

ABDOMINAL FAT; ADIPOSITY; HEALTH STATUS; HUMANS; LONGEVITY; OBESITY;

EID: 84925944353     PISSN: 00741132     EISSN: 16623800     Source Type: Book Series    
DOI: 10.1159/000319991     Document Type: Article

References (111)

1. Matsuzawa Y, Shimomura I, Nakamura T, Keno Y, Tokunaga K: Pathophysiology and pathogenesis of visceral fat obesity. Ann NY Acad Sci 1995;748:399-406.
2. Huffman DM, Barzilai, N: Role of visceral adipose tissue in aging. Biochim Biophys Acta 2009;1790:1117-1123.
3. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB: The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003;163:427-436.
4. Freedland SJ, Platz EA: Obesity and prostate cancer: making sense out of apparently conflicting data. Epidemiol Rev 2007.
5. Selwyn AP: Weight reduction and cardiovascular and metabolic disease prevention: clinical trial update. Am J Cardiol 2007;100:33P-37P.
6. Koh-Banerjee P, Wang Y, Hu FB, Spiegelman D, Willett WC, Rimm EB: Changes in body weight and body fat distribution as risk factors for clinical diabetes in US men. Am J Epidemiol 2004;159:1150-1159.
7. Pascot A, Lemieux S, Lemieux I, Prud'homme D, Tremblay A, Bouchard C, Nadeau A, Couillard C, Tchernof A, Bergeron J, Despres JP: Age-related increase in visceral adipose tissue and body fat and the metabolic risk profile of premenopausal women. Diabetes Care 1999;22:1471-1478.
8. Nicklas BJ, Cesari M, Penninx BW, Kritchevsky SB, Ding J, Newman A, Kitzman DW, Kanaya AM, Pahor M, Harris TB: Abdominal obesity is an independent risk factor for chronic heart failure in older people. J Am Geriatr Soc 2006;54:413-420.
9. Walker SP, Rimm EB, Ascherio A, Kawachi I, Stampfer MJ, Willett WC: Body size and fat distribution as predictors of stroke among US men. Am J Epidemiol 1996;144:1143-1150.
10. Whitmer RA, Gustafson DR, Barrett-Connor E, Haan MN, Gunderson EP, Yaffe K: Central obesity and increased risk of dementia more than three decades later. Neurology 2008;71:1057-1064.
11. Razay G, Vreugdenhil A, Wilcock G: Obesity, abdominal obesity and Alzheimer disease. Dement Geriatr Cogn Disord 2006;22:173-176.
12. Vogelzangs N, Kritchevsky SB, Beekman AT, Newman AB, Satterfield S, Simonsick EM, Yaffe K, Harris TB, Penninx BW: Depressive symptoms and change in abdominal obesity in older persons. Arch Gen Psychiatry 2008;65:1386-1393.
13. Guallar-Castillon P, Sagardui-Villamor J, Banegas JR, Graciani A, Fornes NS, Lopez Garcia E, Rodriguez-Artalejo F: Waist circumference as a predictor of disability among older adults. Obesity (Silver Spring) 2007;15:233-244.
14. Hubbard RE, Lang IA, Llewellyn DJ, Rockwood K: Frailty, body mass index, and abdominal obesity in older people. J Gerontol A Biol Sci Med Sci 2010;65:377-381.
15. Yamaji T, Iwasaki M, Sasazuki S, Kurahashi N, Mutoh M, Yamamoto S, Suzuki M, Moriyama N, Wakabayashi K, Tsugane S: Visceral fat volume and the prevalence of colorectal adenoma. Am J Epidemiol 2009;170:1502-1511.
16. Ohki T, Tateishi R, Shiina S, Goto E, Sato T, Nakagawa H, Masuzaki R, Goto T, Hamamura K, Kanai F, Yoshida H, Kawabe T, Omata M: Visceral fat accumulation is an independent risk factor for hepatocellular carcinoma recurrence after curative treatment in patients with suspected NASH. Gut 2009;58:839-844.
17. von Hafe P, Pina F, Perez A, Tavares M, Barros H: Visceral fat accumulation as a risk factor for prostate cancer. Obes Res 2004;12:1930-1935.
18. Gilsanz V, Chalfant J, Mo AO, Lee DC, Dorey FJ, Mittelman SD: Reciprocal relations of subcutaneous and visceral fat to bone structure and strength. J Clin Endocrinol Metab 2009;94:3387-3393.
19. Gabriely I, Ma XH, Yang XM, Atzmon G, Rajala MW, Berg AH, Scherer P, Rossetti L, Barzilai N: Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokinemediated process? Diabetes 2002;51:2951-2958.
20. Bjorntorp P: 'Portal' adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 1990;10:493-496.
21. Boden G: Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes. Exp Clin Endocrinol Diabetes 2003;111:121-124.
22. Kim SP, Catalano KJ, Hsu IR, Chiu JD, Richey JM, Bergman RN: Nocturnal free fatty acids are uniquely elevated in the longitudinal development of dietinduced insulin resistance and hyperinsulinemia. Am J Physiol Endocrinol Metab 2007;292:E1590-E1598.
23. Nielsen S, Guo Z, Johnson CM, Hensrud DD, Jensen MD: Splanchnic lipolysis in human obesity. J Clin Invest 2004;113:1582-1588.
24. Trayhurn P, Wood IS: Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans 2005;33:1078-1081.
25. Cartier A, Cote M, Lemieux I, Perusse L, Tremblay A, Bouchard C, Despres JP: Age-related differences in inflammatory markers in men: contribution of visceral adiposity. Metabolism 2009;58:1452-1458.
26. Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S: Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 2007;56:1010-1013.
27. Atzmon G, Yang XM, Muzumdar R, Ma XH, Gabriely I, Barzilai N: Differential gene expression between visceral and subcutaneous fat depots. Horm Metab Res 2002;34:622-628.
28. Einstein FH, Atzmon G, Yang XM, Ma XH, Rincon M, Rudin E, Muzumdar R, Barzilai N: Differential responses of visceral and subcutaneous fat depots to nutrients. Diabetes 2005;54:672-678.
29. Giusti V, Suter M, Verdumo C, Gaillard RC, Burckhardt P, Pralong FP: Molecular determinants of human adipose tissue: differences between visceral and subcutaneous compartments in obese women. J Clin Endocrinol Metab 2004;89:1379-1384.
30. van Herpen NA, Schrauwen-Hinderling VB: Lipid accumulation in non-adipose tissue and lipotoxicity. Physiol Behav 2008;94:231-241.
31. Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, Ilkayeva O, Bain J, Stevens R, Dyck JR, Newgard CB, Lopaschuk GD, Muoio DM: Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 2008;7:45-56.
32. Coen PM, Dube JJ, Amati F, Stefanovic-Racic M, Ferrell RE, Toledo FG, Goodpaster BH: Insulin resistance is associated with higher intramyocellular triglycerides in type I but not type II myocytes concomitant with higher ceramide content. Diabetes 2010;59:80-88.
33. Pan DA, Lillioja S, Kriketos AD, Milner MR, Baur LA, Bogardus C, Jenkins AB, Storlien LH: Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 1997;46:983-88.
34. Kim JK, Fillmore JJ, Chen Y, Yu C, Moore IK, Pypaert M, Lutz EP, Kako Y, Velez-Carrasco W, Goldberg IJ, Breslow JL, Shulman GI: Tissuespecific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci USA 2001;98:7522-7527.
35. Almeda-Valdes P, Cuevas-Ramos D, Aguilar-Salinas CA: Metabolic syndrome and non-alcoholic fatty liver disease. Ann Hepatol 2009;8(suppl 1):S18-S24.
36. Siegel AB, Zhu AX: Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link. Cancer 2009;115:5651-5661.
37. Korenblat KM, Fabbrini E, Mohammed BS, Klein S: Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. Gastroenterology 2008;134:1369-1375.
38. Hwang JH, Stein DT, Barzilai N, Cui MH, Tonelli J, Kishore P, Hawkins M: Increased intrahepatic triglyceride is associated with peripheral insulin resistance: in vivo MR imaging and spectroscopy studies. Am J Physiol Endocrinol Metab 2007;293:E1663-E1669.
39. Fabbrini E, Magkos F, Mohammed BS, Pietka T, Abumrad NA, Patterson BW, Okunade A, Klein S: Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci USA 2009;106:15430-15435.
40. van Der Poorten D, Milner KL, Hui J, Hodge A, Trenell MI, Kench JG, London R, Peduto T, Chisholm DJ, George J: Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology 2008;48:449-457.
41. Greenstein AS, Khavandi K, Withers SB, Sonoyama K, Clancy O, Jeziorska M, Laing I, Yates AP, Pemberton PW, Malik RA, Heagerty AM: Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation 2009;119:1661-1670.
42. Carr DB, Utzschneider KM, Hull RL, Kodama K, Retzlaff BM, Brunzell JD, Shofer JB, Fish BE, Knopp RH, Kahn SE: Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 2004;53:2087-2094.
43. Buettner R, Scholmerich J, Bollheimer LC: High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity (Silver Spring) 2007;15:798-808.
44. Powell CS, Blaylock ML, Wang R, Hunter HL, Johanning GL, Nagy TR: Effects of energy expenditure and Ucp1 on photoperiod-induced weight gain in collard lemmings. Obes Res 2002;10:541-550.
45. Davey RA, MacLean HE: Current and future approaches using genetically modified mice in endocrine research. Am J Physiol Endocrinol Metab 2006;291:E429-E438.
46. Friedman JM, Halaas JL: Leptin and the regulation of body weight in mammals. Nature 1998;395:763-770.
47. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS: A transgenic model of visceral obesity and the metabolic syndrome. Science 2001;294:2166-2170.
48. Barzilai N, She L, Liu BQ, Vuguin P, Cohen P, Wang J, Rossetti L: Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes 1999;48:94-98.
49. Ohman MK, Shen Y, Obimba CI, Wright AP, Warnock M, Lawrence DA, Eitzman DT. Visceral adipose tissue inflammation accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation 2008;117:798-805.
50. Tran TT, Yamamoto Y, Gesta S, Kahn CR: Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab 2008;7:410-420.
51. Einstein FH, Fishman S, Muzumdar RH, Yang XM, Atzmon G, Barzilai N: Accretion of visceral fat and hepatic insulin resistance in pregnant rats. Am J Physiol Endocrinol Metab 2007.
52. Borst SE, Conover CF, Bagby GJ: Association of resistin with visceral fat and muscle insulin resistance. Cytokine 2005;32:39-44.
53. Pitombo C, Araujo EP, De Souza CT, Pareja JC, Geloneze B, Velloso LA: Amelioration of dietinduced diabetes mellitus by removal of visceral fat. J Endocrinol 2006;191:699-706.
54. Shi H, Strader AD, Woods SC, Seeley RJ: The effect of fat removal on glucose tolerance is depot specific in male and female mice. Am J Physiol Endocrinol Metab 2007;293:E1012-E1020.
55. Shi H, Strader AD, Woods SC, Seeley RJ: Sexually dimorphic responses to fat loss after caloric restriction or surgical lipectomy. Am J Physiol Endocrinol Metab 2007;293:E316-E326.
56. Lottati M, Kolka CM, Stefanovski D, Kirkman EL, Bergman RN: Greater omentectomy improves insulin sensitivity in nonobese dogs. Obesity (Silver Spring) 2009;17:674-680.
57. Thorne A, Lonnqvist F, Apelman J, Hellers G, Arner P: A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding. Int J Obes Relat Metab Disord 2002;26:193-199.
58. Bjorntorp P: Obesity and the risk of cardiovascular disease. Ann Clin Res 1985;17:3-9.
59. Bluher M: The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Curr Opin Lipidol 2010;21:38-43.
60. Goodpaster BH, Thaete FL, Simoneau JA, Kelley DE: Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 1997;46:1579-1585.
61. Porter SA, Massaro JM, Hoffmann U, Vasan RS, O'Donnel CJ, Fox CS: Abdominal subcutaneous adipose tissue: a protective fat depot? Diabetes Care 2009;32:1068-1075.
62. Klein S, Fontana L, Young VL, Coggan AR, Kilo C, Patterson BW, Mohammed BS: Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med 2004;350:2549-2557.
63. Mohammed BS, Cohen S, Reeds D, Young VL, Klein S: Long-term effects of large-volume liposuction on metabolic risk factors for coronary heart disease. Obesity (Silver Spring) 2008;16:2648-2651.
64. Busetto L, Bassetto F, Zocchi M, Zuliani F, Nolli ML, Pigozzo S, Coin A, Mazza M, Sergi G, Mazzoleni F, Enzi G: The effects of the surgical removal of subcutaneous adipose tissue on energy expenditure and adipocytokine concentrations in obese women. Nutr Metab Cardiovasc Dis 2008;18:112-120.
65. Ybarra J, Blanco-Vaca F, Fernandez S, Castellvi A, Bonet R, Palomer X, Ordonez-Llanos J, Trius A, Vila-Rovira R, Perez A: The effects of liposuction removal of subcutaneous abdominal fat on lipid metabolism are independent of insulin sensitivity in normal-overweight individuals. Obes Surg 2008;18:408-414.
66. Kim JY, van de Wall E, Laplante M, Azzara A, Trujillo ME, Hofmann SM, Schraw T, Durand JL, Li H, Li G, Jelicks LA, Mehler MF, Hui DY, Deshaies Y, Shulman GI, Schwartz GJ, Scherer PE: Obesity associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 2007;117:2621-2637.
67. Saltiel AR, Olefsky JM: Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 1996;45:1661-1669.
68. Boden G, Cheung P, Mozzoli M, Fried SK: Effect of thiazolidinediones on glucose and fatty acid metabolism in patients with type 2 diabetes. Metabolism 2003;52:753-759.
69. Teranishi T, Ohara T, Maeda K, Zenibayashi M, Kouyama K, Hirota Y, Kawamitsu H, Fujii M, Sugimura K, Kasuga M: Effects of pioglitazone and metformin on intracellular lipid content in liver and skeletal muscle of individuals with type 2 diabetes mellitus. Metabolism 2007;56:1418-1424.
70. Sandouk T, Reda D, Hofmann C: Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells. Am J Physiol 1993;264:C1600-C1608.
71. McLaughlin TM, Liu T, Yee G, Abbasi F, Lamendola C, Reaven G, Tsao P, Cushman S, Sherman A: Pioglitazone increases the proportion of small cells in human abdominal subcutaneous adipose tissue. Obesity (Silver Spring) 2009.
72. Adams M, Montague CT, Prins JB, Holder JC, Smith SA, Sanders L, Digby JE, Sewter CP, Lazar MA, Chatterjee VK, O'Rahilly S: Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation. J Clin Invest 1997;100:3149-3153.
73. Bartke A: Insulin and aging. Cell Cycle 2008;7:3338-3343.
74. Berryman DE, List EO, Palmer AJ, Chung MY, Wright-Piekarski J, Lubbers E, O'Connor P, Okada S, Kopchick JJ: Two-year body composition analyses of long-lived GHR null mice. J Gerontol A Biol Sci Med Sci 2010;65:31-40.
75. Rissanen A, Heliovaara M, Knekt P, Aromaa A, Reunanen A, Maatela J: Weight and mortality in Finnish men. J Clin Epidemiol 1989;42:781-789.
76. Lindsted K, Tonstad S, Kuzma JW: Body mass index and patterns of mortality among Seventh-day Adventist men. Int J Obes 1991;15:397-406.
77. Bender R, Jockel KH, Trautner C, Spraul M, Berger M: Effect of age on excess mortality in obesity. JAMA 1999;281:1498-1504.
78. Allison DB, Fontaine KR, Manson JE, Stevens J, Van Itallie TB: Annual deaths attributable to obesity in the United States. JAMA 1999;282:1530-1538.
79. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB: Years of life lost due to obesity. JAMA 2003;289:187-193.
80. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 2003;348:1625-1638.
81. Valdes AM, Andrew T, Gardner JP, Kimura M, Oelsner E, Cherkas LF, Aviv A, Spector TD: Obesity, cigarette smoking, and telomere length in women. Lancet 2005;366:662-664.
82. Stevens J, Keil JE, Rust PF, Tyroler HA, Davis CE, Gazes PC: Body mass index and body girths as predictors of mortality in black and white women. Arch Intern Med 1992;152:1257-1262.
83. Folsom AR, Kaye SA, Sellers TA, Hong CP, Cerhan JR, Potter JD, Prineas RJ: Body fat distribution and 5-year risk of death in older women. JAMA 1993;269:483-487.
84. Baik I, Ascherio A, Rimm EB, Giovannucci E, Spiegelman D, Stampfer MJ, Willett WC: Adiposity and mortality in men. Am J Epidemiol 2000;152:264-271.
85. Wannamethee SG, Shaper AG, Lennon L, Whincup PH: Decreased muscle mass and increased central adiposity are independently related to mortality in older men. Am J Clin Nutr 2007;86:1339-1346.
86. Pischon T, Boeing H, Hoffmann, et al: General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008;359:2105-2120.
87. Postorino M, Marino C, Tripepi G, Zoccali C: Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease. J Am Coll Cardiol 2009;53:1265-1272.
88. Reis JP, Macera CA, Araneta MR, Lindsay SP, Marshall SJ, Wingard DL: Comparison of overall obesity and body fat distribution in predicting risk of mortality. Obesity (Silver Spring) 2009;17:1232-1239.
89. Kuk JL, Ardern CI: Influence of age on the association between various measures of obesity and allcause mortality. J Am Geriatr Soc 2009.
90. Price GM, Uauy R, Breeze E, Bulpitt CJ, Fletcher AE: Weight, shape, and mortality risk in older persons: elevated waist-hip ratio, not high body mass index, is associated with a greater risk of death. Am J Clin Nutr 2006;84:449-460.
91. Rimm EB, Stampfer MJ, Giovannucci E, Ascherio A, Spiegelman D, Colditz GA, Willett WC: Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol 1995;141:1117-1127.
92. Tannenbaum A: The genesis and growth of tumors. II. Effects of caloric restriction per se. Cancer Res 1942;2:460-464.
93. Tannenbaum A: The dependence of the genesis of induced skin tumors on the caloric intake during different stages of carcinogenesis. Cancer Res 1944;4:673-679.
94. Nutrition Classics: The American Journal of Cancer, Volume XXXVIII, March, 1940: The initiation and growth of tumors. Introduction. I. Effects of underfeeding. By Albert Tannenbaum. Nutr Rev 1987;45:20-22.
95. Weindruch R, Walford R: The Retardation of Aging and Disease by Dietary Restriction. Springfield, Thomas, 1988.
96. Pugh TD, Klopp RG, Weindruch R: Controlling caloric consumption: protocols for rodents and rhesus monkeys. Neurobiol Aging 1999;20:157-165.
97. Bertrand HA, Lynd FT, Masoro EJ, Yu BP: Changes in adipose mass and cellularity through the adult life of rats fed ad libitum or a life-prolonging restricted diet. J Gerontol 1980;35:827-835.
98. Masoro EJ: Commentary on 'Revisiting the role of fat mass in the life extension induced by caloric restriction'. J Gerontol A Biol Sci Med Sci 1999;54A:B97.
99. Speakman JR: Body size, energy metabolism and life span. J Exp Biol 2005;208:1717-1730.
100. Bluher M, Kahn BB, Kahn CR: Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 2003;299:572-574.
101. Barzilai N, Gupta G: Revisiting the role of fat mass in the life extension induced by caloric restriction. J Gerontol A Biol Sci Med Sci 1999;54:B89-B96; discussion B97-B98.
102. Harrison DE, Archer JR, Astle CM: Effects of food restriction on aging: separation of food intake and adiposity. Proc Natl Acad Sci USA 1984;81:1835-1838.
103. Berg BN, Simms HS: Nutrition and longevity in the rat. II. Longevity and onset of disease with different levels of food intake. J Nutr 1960;71:255-263.
104. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-432.
105. Frankenberry KA, Somasundar P, McFadden DW, Vona-Davis LC: Leptin induces cell migration and the expression of growth factors in human prostate cancer cells. Am J Surg 2004;188:560-565.
106. Rose DP, Komninou D, Stephenson GD: Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev 2004;5:153-165.
107. Barzilai N, Banerjee S, Hawkins M, Chen W, Rossetti L: Caloric restriction reverses hepatic insulin resistance in aging rats by decreasing visceral fat. J Clin Invest 1998;101:1353-1361.
108. Weindruch R: The retardation of aging by caloric restriction: studies in rodents and primates. Toxicol Pathol 1996;24:742-745.
109. Wang C, Weindruch R, Fernandez JR, Coffey CS, Patel P, Allison DB: Caloric restriction and body weight independently affect longevity in Wistar rats. Int J Obes Relat Metab Disord 2004;28:357-362.
110. Muzumdar R, Allison DB, Huffman DM, Ma X, Atzmon G, Einstein FH, Fishman S, Poduval AD, McVei T, Keith SW, Barzilai N: Visceral adipose tissue modulates mammalian longevity. Aging Cell 2008;7:438-440.
111. Kim YW, Kim JY, Lee SK: Surgical removal of visceral fat decreases plasma free fatty acid and increases insulin sensitivity on liver and peripheral tissue in monosodium glutamate (MSG)-obese rats. J Korean Med Sci 1999;14:539-545.